FDA NDC Directory · JSON-LD · Markdown

Jemperli

NDC 0173-0898 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic namedostarlimab
Labeler / ManufacturerGlaxoSmithKline LLC
Marketing categoryBiologic License Application · App BLA761174
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsDOSTARLIMAB (50 mg/mL)
Marketing started20210422
Package count1

External sources

Source: openFDA. Public-domain (CC0).